DNMT3B and neoplasm: The mRNA expression of DNMT1, DNMT3b, HDAC1 and HDAC2 were particularly prominent in high-grade tumors in ovarian cancers, which indicated that they may be the biomarkers of tumor aggressiveness and proliferation, as their high expression is closely associated with ovarian carcinoma progression.